Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Receivables - Net (2020 - 2025)

Historic Receivables - Net for Strata Critical Medical (SRTA) over the last 6 years, with Q3 2025 value amounting to $37.5 million.

  • Strata Critical Medical's Receivables - Net rose 5333.52% to $37.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.5 million, marking a year-over-year increase of 5333.52%. This contributed to the annual value of $19.8 million for FY2024, which is 563.2% down from last year.
  • Latest data reveals that Strata Critical Medical reported Receivables - Net of $37.5 million as of Q3 2025, which was up 5333.52% from $28.2 million recorded in Q2 2025.
  • Strata Critical Medical's Receivables - Net's 5-year high stood at $37.5 million during Q3 2025, with a 5-year trough of $1.7 million in Q2 2021.
  • Moreover, its 5-year median value for Receivables - Net was $20.4 million (2023), whereas its average is $17.4 million.
  • As far as peak fluctuations go, Strata Critical Medical's Receivables - Net surged by 46495.33% in 2022, and later crashed by 603.82% in 2025.
  • Quarter analysis of 5 years shows Strata Critical Medical's Receivables - Net stood at $5.5 million in 2021, then skyrocketed by 96.05% to $10.9 million in 2022, then soared by 93.11% to $21.0 million in 2023, then fell by 5.63% to $19.8 million in 2024, then skyrocketed by 89.38% to $37.5 million in 2025.
  • Its Receivables - Net stands at $37.5 million for Q3 2025, versus $28.2 million for Q2 2025 and $22.1 million for Q1 2025.